e-drug
[Top] [All Lists]

[e-drug] IP and generics in Europe

E-DRUG: IP and generics in Europe
------------------------------

In case you have not seen this, I draw your
attention to the recent report of the EGA on IP and generic competition
in Europe, 

PATENT-RELATED BARRIERS TO MARKET ENTRY FOR GENERIC MEDICINES IN THE 
EUROPEAN UNION:  A review of weaknesses in the current European patent system 
and their impact on the market access of generic medicines 

Patents play an important role in modern society, encouraging the creation, 
dissemination and efficient exploitation of new technology.

Generic medicines play an equally important role in promoting pharmaceutical 
innovation, affordability and sustainability. Immediate market access of 
generic medicines after patent expiry is crucial to society.

When patents?of sometimes questionable quality?are misused merely to prevent 
others from innovating and competing, they can present a formidable barrier to 
entry onto the generic medicines market.

This report identifies some of the patent-related hurdles facing generic 
medicines in the European Union.

see the full report and presse release at 

http://www.egagenerics.com/

Best wishes

Kees de Joncheere
Regional Adviser Health Technology and Pharmaceuticals
WHO Regional office for Europe
8 Scherfigsvej, 2100 Copenhagen, Denmark
tel 45-39171432
fax 45-39171855
email cjo@euro.who.int
website http://www.euro.who.int/pharmaceuticals 


<Prev in Thread] Current Thread [Next in Thread>